A Special Episode on Potential Breakthroughs in COVID-19 Research Coming from Cancer Research by the Prostate Cancer Foundation and FasterCures

 A video recording of this episode – with helpful graphics – is also available at mikemilken.com.

For our 50th recording, Jonathan Simons (President and CEO, Prostate Cancer Foundation) and Esther Krofah (Executive Director, FasterCures) join Mike for a special discussion about how breakthroughs in cancer laboratories are advancing our understanding and possible treatment of COVID-19. 

The roundtable discussion features six scientists from academic medical research institutions and the biopharmaceutical industry sharing their insights on the TMPRSS2 gene’s role as the doorway through which the SARS-CoV-2 virus enters the lung. That same genetic doorway also happens to play an important role in several forms of cancer. The promising news is that researchers – including those on this call – have learned how to shut that door in other contexts.